Skip to main content
. 2017 Jan 22;8(9):14416–14427. doi: 10.18632/oncotarget.14796

Table 3. Univariate analysis of immune cell markers in all patients.

Markers LRC (HR, 95% CI) P value OS (HR, 95% CI) P value
PD-L1 0.67, 0.34–3.50 0.78 1.21, 0.51–2.80 0.65
CD8+ 0.45, 0.54–4.50 0.87 1.03, 0.49–2.13 0.93
CD68+ 1.40, 0.24–2.30 0.65 1.24, 0.59–2.60 0.55
CD68+PD-L1+ 0.56, 0.34–2.60 0.89 0.68, 0.32–1.41 0.30
CD8+PD-1+ 1.10, 0.45–3.40 0.57 0.72, 0.34–1.53 0.40